Search research articles
Contact Us
Filters
Showing results (401-410 of 420) with videos related to
Page
of 42
Sort By:
Diagnostic Microbiology and Infectious Disease
|
January 1, 1988
Effect of clavulanic acid on the susceptibility of clinical anaerobic bacteria to ticarcillin: a multicenter study
P C Fuchs, R N Jones, A L Barry, et al.
European Journal of Epidemiology
|
November 1, 1993
In vitro activity of ceftriaxone and other cephalosporins against 602 clinical isolates of staphylococci from geographically diverse medical centers
M A Pfaller, A L Barry, L D Sabath, et al.
Antimicrobial Agents and Chemotherapy
|
April 1, 1989
Multicenter in vitro evaluation of SM-7338, a new carbapenem
R N Jones, K E Aldridge, S D Allen, et al.
Diagnostic Microbiology and Infectious Disease
|
August 1, 1988
Multicenter in vitro evaluation of lomefloxacin (NY-198, SC-47111), including tests against nearly 7,000 bacterial isolates and preliminary recommendations for susceptibility testing
R N Jones, K E Aldridge, A L Barry, et al.
Journal of Clinical Microbiology
|
March 1, 1993
Susceptibility of Haemophilus influenzae to piperacillin-tazobactam combinations: interpretive criteria and quality control limits for standardized tests
A L Barry, P C Fuchs, J H Jorgensen, et al.
Journal of Clinical Microbiology
|
July 1, 1987
Collaborative clinical laboratory study of a broth-disk test for determination of bacterial susceptibility to beta-lactams in combination with amdinocillin
H D Isenberg, R C Tilton, A L Barry, et al.
Journal of Clinical Microbiology
|
July 1, 1986
Selection of a reference lot of Mueller-Hinton agar
H M Pollock, A L Barry, T L Gavan, et al.
Antimicrobial Agents and Chemotherapy
|
November 1, 1982
Cefotetan, a new cephamycin: comparison of in vitro antimicrobial activity with other cephems, beta-lactamase stability, and preliminary recommendations for disk diffusion testing
L W Ayers, R N Jones, A L Barry, et al.
Journal of Clinical Microbiology
|
June 1, 1985
Ciprofloxacin disk susceptibility tests: interpretive zone size standards for 5-microgram disks
A L Barry, R J Fass, J P Anhalt, et al.
Journal of Clinical Microbiology
|
March 1, 1992
Revision of standards for adjusting the cation content of Mueller-Hinton broth for testing susceptibility of Pseudomonas aeruginosa to aminoglycosides
A L Barry, L B Reller, G H Miller, et al.
Page
of 42
Search research articles
Search
Showing results (401-410 of 420) with videos related to
Sort By:
Page
of 42
Diagnostic Microbiology and Infectious Disease
|
January 1, 1988
Effect of clavulanic acid on the susceptibility of clinical anaerobic bacteria to ticarcillin: a multicenter study
P C Fuchs, R N Jones, A L Barry, et al.
European Journal of Epidemiology
|
November 1, 1993
In vitro activity of ceftriaxone and other cephalosporins against 602 clinical isolates of staphylococci from geographically diverse medical centers
M A Pfaller, A L Barry, L D Sabath, et al.
Antimicrobial Agents and Chemotherapy
|
April 1, 1989
Multicenter in vitro evaluation of SM-7338, a new carbapenem
R N Jones, K E Aldridge, S D Allen, et al.
Diagnostic Microbiology and Infectious Disease
|
August 1, 1988
Multicenter in vitro evaluation of lomefloxacin (NY-198, SC-47111), including tests against nearly 7,000 bacterial isolates and preliminary recommendations for susceptibility testing
R N Jones, K E Aldridge, A L Barry, et al.
Journal of Clinical Microbiology
|
March 1, 1993
Susceptibility of Haemophilus influenzae to piperacillin-tazobactam combinations: interpretive criteria and quality control limits for standardized tests
A L Barry, P C Fuchs, J H Jorgensen, et al.
Journal of Clinical Microbiology
|
July 1, 1987
Collaborative clinical laboratory study of a broth-disk test for determination of bacterial susceptibility to beta-lactams in combination with amdinocillin
H D Isenberg, R C Tilton, A L Barry, et al.
Journal of Clinical Microbiology
|
July 1, 1986
Selection of a reference lot of Mueller-Hinton agar
H M Pollock, A L Barry, T L Gavan, et al.
Antimicrobial Agents and Chemotherapy
|
November 1, 1982
Cefotetan, a new cephamycin: comparison of in vitro antimicrobial activity with other cephems, beta-lactamase stability, and preliminary recommendations for disk diffusion testing
L W Ayers, R N Jones, A L Barry, et al.
Journal of Clinical Microbiology
|
June 1, 1985
Ciprofloxacin disk susceptibility tests: interpretive zone size standards for 5-microgram disks
A L Barry, R J Fass, J P Anhalt, et al.
Journal of Clinical Microbiology
|
March 1, 1992
Revision of standards for adjusting the cation content of Mueller-Hinton broth for testing susceptibility of Pseudomonas aeruginosa to aminoglycosides
A L Barry, L B Reller, G H Miller, et al.
Page
of 42